MDGL EPS Estimates
Madrigal Pharmaceuticals, Inc.
$460.01
+$7.89(+1.75%)
40
Overall
40
Value
36
Tech
44
Quality
Market Cap
$10.63B
Volume
326.94K
52W Range
$393.61 - $615.00
Target Price
$675.50
MDGL EPS estimates: the consensus estimate for Madrigal Pharmaceuticals, Inc.'s current fiscal year is -$7.03 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
MDGL EPS Estimates
- EPS estimate, current quarter
- $-1.00
- EPS estimate, next quarter
- $-0.57
- EPS estimate, current year
- $-7.03
- EPS estimate, next year
- $5.55
- EPS growth, 3-year
- +9.31%
| Fiscal year | EPS |
|---|---|
| 2025 | $-12.85 |
| 2024 | $-21.90 |
| 2023 | $-19.99 |
| 2022 | $-17.23 |
| 2021 | $-14.63 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | MDGL | $460.01 | +1.7% | 326.94K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Madrigal Pharmaceuticals, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW